Filter AI tools by vendor, specific workflows, and critical features
HealthyData.Science’s directory is a curated catalogue of AI tools for healthcare and life sciences, giving leaders a neutral starting point to shortlist and compare options across clinical, operational, commercial, and regulatory use cases. It is aimed at roles such as CMIOs, CDOs, service line leads, clinical development and pharmacovigilance heads, commercial and market‑access teams, and MedTech product or regulatory leaders.
Tools are organised by domain (Clinical AI and Diagnostics, Drug Development and Research, Digital Health, Commercial & Market Access, Regulatory & Compliance), by workflow (for example, clinical trials, pharmacovigilance, medical imaging, AI agents, remote patient monitoring), and by key features such as clinical‑trial support, clinical validation, regulatory‑ready design, or EHR integration. The listings below go beyond basic marketing copy, combining neutral analysis with real‑world use cases, evidence summaries, regulatory posture, and governance considerations for high‑impact areas such as clinical trials, drug discovery, and regulatory intelligence.
HealthyData.Science reviews publicly available information for each tool, including technical documentation, healthcare use cases, evidence summaries, and any disclosed certifications or regulatory clearances. Tools are then profiled using a consistent structure that covers intended use, deployment model, evidence and validation, regulatory status, and known risks or limitations.
No. The tools listed in this directory are intended to support, not replace, the judgment of clinicians, safety professionals, and regulatory or quality teams. Any use in patient‑impacting, GxP, or regulatory workflows should follow local governance processes, with human review and approval remaining mandatory.
Regulatory and evidence information is based on what vendors and regulators make public at the time of review. HealthyData.Science periodically revisits high‑impact tools and categories, but organisations should always confirm the latest regulatory status, indications for use, and validation evidence directly with vendors and relevant authorities before deployment.
This directory is designed as an early‑stage discovery and shortlisting resource, helping teams compare tools by use case, deployment model, and reported evidence. It should be combined with internal requirements gathering, security and privacy assessments, vendor due diligence, and formal procurement and validation processes.
Yes. Vendors and users can submit updates or corrections if information is incomplete or out of date, and HealthyData.Science will review these against available evidence before making changes. This helps keep the directory neutral, accurate, and aligned with real‑world use.
